Terms: = Uterine cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Treatment
46 results:
1. Using Silva pattern system to predict prognosis and plan treatment of invasive endocervical adenocarcinoma: a single-center retrospective analysis.
Li X; Pang S; Shen Y; Qu P
BMC Womens Health; 2022 Dec; 22(1):488. PubMed ID: 36460984
[TBL] [Abstract] [Full Text] [Related]
2. The effect of preserving pregnancy in cervical cancer diagnosed during pregnancy: a retrospective study.
He Z; Xie C; Qi X; Hu Z; He Y
BMC Womens Health; 2022 Jul; 22(1):314. PubMed ID: 35879712
[TBL] [Abstract] [Full Text] [Related]
3. Clinical characteristic and prognostic factors in high-grade endometrial neuroendocrine carcinoma.
Zhang Z; Wang J; Wu X; Liu Y; Xi X
J Obstet Gynaecol Res; 2022 Aug; 48(8):2180-2188. PubMed ID: 35778826
[TBL] [Abstract] [Full Text] [Related]
4. Tumoral Morphologic Features From Cervical Biopsies That Are Predictive of a Negligible Risk for Nodal Metastasis and Tumor Recurrence in Usual-type Cervical Adenocarcinomas: A Multi-institutional Study.
Wang Y; Chang RJ; Luo RZ; Yu J; Zhang X; Yang X; Quddus MR; Li L; Yang W; Liu A; Jiang Q; Zhao R; Zhu H; Zhou F; Wang Y; Sheng X; Liu LL; Wen YL; Banet N; Sung CJ; Qi Y; Bi R; Li M; Wang Y; Li J; Lin W; Wang Y; Rivera G; Chen H; Holloway SB; Fadare O; Liu J; Wang J; Lea J; Kong B; Zheng W
Am J Surg Pathol; 2022 May; 46(5):713-724. PubMed ID: 34753864
[TBL] [Abstract] [Full Text] [Related]
5. Outcomes of the conservative management of the patients with endometrial intraepithelial neoplasia/endometrial cancer: Wait or treat!
İşçi Bostancı E; Durmuş Y; Duru Çöteli AS; Kayıkçıoğlu F; Boran N
Turk J Med Sci; 2021 Aug; 51(4):2066-2072. PubMed ID: 34013707
[TBL] [Abstract] [Full Text] [Related]
6. Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial.
Janda M; Robledo KP; Gebski V; Armes JE; Alizart M; Cummings M; Chen C; Leung Y; Sykes P; McNally O; Oehler MK; Walker G; Garrett A; Tang A; Land R; Nicklin JL; Chetty N; Perrin LC; Hoet G; Sowden K; Eva L; Tristram A; Obermair A
Gynecol Oncol; 2021 Apr; 161(1):143-151. PubMed ID: 33762086
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathologic characteristics and prognosis comparison of the uterine high grade endometrial carcinomas.
Sucu M; Kucukgoz Gulec U; Paydas S; Guzel AB; Kilic Bagir E; Vardar MA
Ginekol Pol; 2021; 92(4):278-283. PubMed ID: 33751504
[TBL] [Abstract] [Full Text] [Related]
8. Utilization and survival outcomes of sequential, concurrent and sandwich therapies for advanced stage endometrial cancers by histology.
Ko EM; Brensinger CM; Cory L; Giuntoli RL; Haggerty AF; Latif NA; Aviles D; Martin L; Morgan MA; Lin LL
Gynecol Oncol; 2020 Nov; 159(2):394-401. PubMed ID: 32800655
[TBL] [Abstract] [Full Text] [Related]
9. Feasibility of intravoxel incoherent motion diffusion-weighted imaging in distinguishing adenocarcinoma originated from uterine corpus or cervix.
Zhang Q; Ouyang H; Ye F; Song Y; Xie L; Zhao X; Yu X
Abdom Radiol (NY); 2021 Feb; 46(2):732-744. PubMed ID: 32671441
[TBL] [Abstract] [Full Text] [Related]
10. Is India's public health care system prepared for cervical cancer screening?: Evaluating facility readiness from the fourth round of the District Level Household and Facility Survey (DLHS-4).
Dhillon PK; Hallowell BD; Agrawal S; Ghosh A; Yadav A; Van Dyne E; Senkomago V; Patel SA; Saraf D; Hariprasad R; Dumka N; Mehrotra R; Saraiya M
Prev Med; 2020 Sep; 138():106147. PubMed ID: 32473272
[TBL] [Abstract] [Full Text] [Related]
11. Effects of green synthesised silver nanoparticles (ST06-AgNPs) using curcumin derivative (ST06) on human cervical cancer cells (HeLa) in vitro and eac tumor bearing mice models.
Murugesan K; Koroth J; Srinivasan PP; Singh A; Mukundan S; Karki SS; Choudhary B; Gupta CM
Int J Nanomedicine; 2019; 14():5257-5270. PubMed ID: 31409988
[TBL] [Abstract] [Full Text] [Related]
12. Transforming human papillomavirus infection and the esophageal transformation zone: prime time for total excision/ablative therapy?
Rajendra S; Sharma P
Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 31304554
[TBL] [Abstract] [Full Text] [Related]
13. Molecular expression characteristics confirm the malignancy concealed by morphological alterations in endometrial cancer after fertility-preserving treatment.
Hu TWY; Li L; Yang E; Nie D; Li ZY
Arch Gynecol Obstet; 2019 Jun; 299(6):1673-1682. PubMed ID: 30953185
[TBL] [Abstract] [Full Text] [Related]
14. Challenges and controversies in the conservative management of uterine and ovarian cancer.
Janda M; McGrath S; Obermair A
Best Pract Res Clin Obstet Gynaecol; 2019 Feb; 55():93-108. PubMed ID: 30243603
[TBL] [Abstract] [Full Text] [Related]
15. Study of the revisited, revised, and expanded Silva pattern system for Chinese endocervical adenocarcinoma patients.
Wang W; Song G; Lin J; Zheng X; Wang Y; Liu Y; Liu C
Hum Pathol; 2019 Feb; 84():35-43. PubMed ID: 30218754
[TBL] [Abstract] [Full Text] [Related]
16. Value of combined adjuvant chemotherapy and radiation on survival for stage III uterine cancer: is less radiation equal to more?
Wang CJ; Christie A; Folkert MR; Xie XJ; Albuquerque K
J Gynecol Oncol; 2018 Jul; 29(4):e49. PubMed ID: 29770620
[TBL] [Abstract] [Full Text] [Related]
17. Hypermethylation of WIF1 and its inhibitory role in the tumor growth of endometrial adenocarcinoma.
Deng X; Hou C; Wang H; Liang T; Zhu L
Mol Med Rep; 2017 Nov; 16(5):7497-7503. PubMed ID: 28944908
[TBL] [Abstract] [Full Text] [Related]
18. miR-202 Suppresses Cell Proliferation by Targeting FOXR2 in Endometrial Adenocarcinoma.
Deng X; Hou C; Liang Z; Wang H; Zhu L; Xu H
Dis Markers; 2017; 2017():2827435. PubMed ID: 28827892
[TBL] [Abstract] [Full Text] [Related]
19. miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in uterine Carcinosarcomas.
Tseng JH; Bisogna M; Hoang LN; Olvera N; Rodriguez-Aguayo C; Lopez-Berestein G; Sood AK; Levine DA; Jelinic P
Sci Rep; 2017 Jun; 7(1):3614. PubMed ID: 28620240
[TBL] [Abstract] [Full Text] [Related]
20. Abnormal mismatch repair and other clinicopathologic predictors of poor response to progestin treatment in young women with endometrial complex atypical hyperplasia and well-differentiated endometrial adenocarcinoma: a consecutive case series.
Zakhour M; Cohen JG; Gibson A; Walts AE; Karimian B; Baltayan A; Aoyama C; Garcia L; Dhaliwal SK; Elashoff D; Amneus M; Walsh C
BJOG; 2017 Sep; 124(10):1576-1583. PubMed ID: 28128512
[TBL] [Abstract] [Full Text] [Related]
[Next]